PaulDenisLegerMD

PubMed

• Bothersome Hot Flashes Following Neoadjuvant Androgen Deprivation Therapy and Stereotactic Body Radiotherapy for Localized Prostate Cancer.
  Sarthak Shah, Abigail Pepin, Simran Jatar, Jessica Hsueh, Lindsey Gallagher
  Cureus. 2024-03-01
• The impact of neoadjuvant relugolix on multi-dimensional patient-reported fatigue.
  Jessica Y Hsueh, Lindsey Gallagher, Min Ji Koh, Sarthak Shah, Malika Danner
  Frontiers in Oncology. 2024-01-01
• 1 citations
  Impact of neoadjuvant relugolix on patient-reported sexual function and bother.
  Jessica Y Hsueh, Lindsey Gallagher, Min Ji Koh, Shaine Eden, Sarthak Shah
  Frontiers in Oncology. 2024-01-01

Journal Articles

• Race/ethnicity difference in the pharmacogenetics of bilirubin-related atazanavir discontinuation  
  1) Leger P., Chirva S., Nwogu J., Tuner M., Richardson D., Baker P., Leonard M., Erdem H., Olson L., Haas D., Pharmacogent Genomics, 1/28/2018
• A Case Report of Severe Type B Lactic Acidosis Following First Dose of Nivolumab in a VHL-Mutated Metastatic Renal Cell Carcinoma.  
  2) Nakajima E., Leger P., Mayer I., Neuss M., Chism D., Rathmell K, Kidney Cancer, 7/2017
• Clinical features of acquired resistance in anti-PD-1 therapy  
  3) Wang D., Zeynep E., Ozgun A., Leger P., Zhao S., Ye F., Luke J., Joseph R., Sosman J., Johnson D., Buchbinder E, Cancer Immunology Research, 5/2017
• Pharmacogenetics of Efavirenz Discontinuation for Reported Central Nervous System Symptoms Appears to Differ by Race  
  4) Leger P., Chirwa S., Turner M., Richardson D., Baker P., Leonard M., Erdem H., Olson L., Haas D.., Pharmacogenetics and Genomics, 10/2016
• Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multi-country open-label randomi...  
  1) Hosseinipour M., Bisson G., Miyahara S. Leger P., Gupta A., The Lancet, 3/2016
• Pharmacogenetics of plasma efavirenz exposure in HIV-infected adults and children in South Africa  
  5) Sinxadi P., Leger P., McIleron H., Smith P., Dave J., Levitt N., Maartens G., Haas D.., Br J Clin Pharmacol, 7/2015
• Multiple Genetic Variants Predict Steady-State Nevirapine Clearance in HIV-infected Cambodians  
  7) Bertrand J., Chou M., Richardson D., Verstuyft C., Leger P., Mentre F., Taburet A., Haas D., Pharmacogenet Genomics., 12/2012
• Virologic, Clinical and Immunologic Responses following Failure of First-line Antiretroviral Therapy in Haiti  
  2) Charles M., Leger P., Severe P., Guiteau C., Apollon A., Gulick R., Johnson W., Pape J., Fitzgerald D, Journal of the International AIDS Society, 6/2012
• 5-Year Survival of Patients with AIDS Receiving Antiretroviral Therapy in Haiti  
  6) Leger P., Charles M., Severe P., Riviere C., Pape J., Fitzgerald D, New England Journal of Medicine, 8/2009
• Antiretroviral Therapy in a Thousand Patients with AIDS in Haiti  
  12) Severe P., Leger P.,Charles M., Noel F., Bonhomme J., Bois G.,George E., Kenel-Pierre S.,Wright P., Gulick R., Johnson W., Pape J.,Fitzgerald D, New England Journal of Medicine, 12/2005
• Join now to see all